CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 16 filers reported holding CLOVIS ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $998,000,000 | -51.1% | 1,000,000 | -53.9% | 0.01% | -69.0% |
| Q1 2021 | $2,040,000,000 | +2.2% | 2,170,000 | 0.0% | 0.03% | -29.3% |
| Q4 2020 | $1,996,000,000 | +1.1% | 2,170,000 | 0.0% | 0.04% | -18.0% |
| Q3 2020 | $1,975,000,000 | +1.1% | 2,170,000 | 0.0% | 0.05% | +16.3% |
| Q2 2020 | $1,953,000,000 | +118.2% | 2,170,000 | +117.0% | 0.04% | +138.9% |
| Q1 2020 | $895,000,000 | -88.8% | 1,000,000 | -91.4% | 0.02% | -87.7% |
| Q1 2016 | $7,960,000,000 | -6.8% | 11,625,000 | +16.2% | 0.15% | +1.4% |
| Q4 2015 | $8,540,000,000 | – | 10,000,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |